Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis

References

• Benson MD, Cohen AS. Generalized amyloid in a family of Swedish origin. A study of 426 family members in seven generations of a new kinship with neuropathy, nephropathy, and central nervous system involvement. Ann Intern Med 1977;86:419–424.
   PubMed Web of Science ®Google Scholar
• Ikeda S, Hanyu N, Hongo M, Yoshioka J, Oguchi H, Yanagisawa N, Kobayashi T, Tsukagoshi H, Ito N, Yokota T. Hereditary generalized amyloidosis with polyneuropathy: clinicopathological study of 65 Japanese patients. Brain 1987;110:315–337.
   PubMed Web of Science ®Google Scholar
• Nakazato M, Shiomi K, Miyazato M, Matsukura S. Type 1 familial amyloidotic polyneuropathy in Japan. Intern Med 1992;31:1335–1338.
   PubMed Web of Science ®Google Scholar
• Holmgren G, Costa PM, Andersson C, Asplund K, Steen L, Beckman L, Nylander PO, Teixeira A, Saraiva MJ, Costa PP. Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Genet 1994;31:351–354.
   PubMed Web of Science ®Google Scholar
• Reilly MM, Adams D, Booth DR, Davis MB, Said G, Laubriat-Bianchin M, Pepys MB, Thomas PK, Harding AE. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain 1995;118:849–856.
   PubMed Web of Science ®Google Scholar
• Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 1995;60:515–521.
   Web of Science ®Google Scholar
• Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 2002;58:1001–1007.
   PubMed Web of Science ®Google Scholar
• Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007;36:411–423.
   PubMed Web of Science ®Google Scholar
• Planté-Bordeneuve V, Ferreira A, Lalu T, Zaros C, Lacroix C, Adams D, Said G. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology 2007;69:693–698.
   PubMed Web of Science ®Google Scholar
• Said G, Planté-Bordeneuve V. Familial amyloid polyneuropathy: a clinico-pathologic study. J Neurol Sci 2009;284:149–154.
   PubMed Web of Science ®Google Scholar
• Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005;62:1057–1062.
   PubMed Web of Science ®Google Scholar
• Ando Y, Suhr OB. Autonomic dysfunction in familial amyloid polyneuropathy (FAP). Amyloid 1998;5:288–300.
   PubMed Web of Science ®Google Scholar
• Misu K, Hattori N, Ando Y, Ikeda S, Sobue G. Anticipation in early- but not late-onset familial amyloid polyenuropathy (TTR Met 30) in Japan. Neurology 2000;55:451–452.
   PubMed Web of Science ®Google Scholar
• Koike H, Misu K, Ikeda S, Ando Y, Nakazato M, Ando E, Yamamoto M, Hattori N, Sobue G. Study group for hereditary neuropathy in Japan. Type I (Transthyretin Met30) familial amyloid polyneuropathy in Japan: early- versus late-onset form. Arch Neurol 2002;59:1771–1776.
   PubMed Web of Science ®Google Scholar
• Misu K, Hattori N, Nagamatsu M, Ikeda S, Ando Y, Nakazato M, Takei Y, Hanyu N, Usui Y, Tanaka F, Late-onset familial amyloid polyneuropathy type I (transthyretin Met 30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan; clinicopathological and genetic features. Brain 1999;122:1951–1962.
   PubMed Web of Science ®Google Scholar
• Koike H, Misu K, Sugiura M, Iijima M, Mori K, Yamamoto M, Hattori N, Mukai E, Ando Y, Ikeda S, Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology 2004;63:129–138.
   PubMed Web of Science ®Google Scholar
• Sobue G, Koike H, Misu K, Hattori N, Yamamoto M, Ikeda S, Ando Y, Nakazato M, Inukai A. Clinicopathologic and genetic features of early- and late-onset FAP type I (FAP ATTR Val30Met) in Japan. Amyloid 2003;10 (Suppl 1):32–38.
   PubMed Web of Science ®Google Scholar
• Conceição I, De Carvalho M. Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal. Muscle Nerve 2007;35:116–118.
   PubMed Web of Science ®Google Scholar
• Koike H, Sobue G. Diagnosis of familial amyloid polyneuropathy: wide-ranged clinicopathological features. Expert Opin Med Diagn 2010;4:323–331.
   PubMedGoogle Scholar
• Ikeda S. Is familial amyloid polyneuropathy rare? DNA testing is changing the concept of this disease. Neurology 2007;69;627–628.
   PubMed Web of Science ®Google Scholar
• Koike H, Kawagashira Y, Iijima M, Yamamoto M, Hattori N, Tanaka F, Hirayama M, Ando Y, Ikeda S, Sobue G. Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci. J Neurol 2008;255:1526–1533.
   PubMed Web of Science ®Google Scholar
• Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, Seymour A, Richardson S, Hawkins PN, Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993;341:1113–1116.
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Wiseman RL, Matteson J, Hammarström P, Miller SR, Sawkar AR, Balch WE, Kelly JW. The biological and chemical basis for tissue-selective amyloid disease. Cell 2005;121:73–85.
   PubMed Web of Science ®Google Scholar
• Terazaki H, Ando Y, Fernandes R, Yamamura K, Maeda S, Saraiva MJ. Immunization in familial amyloidotic polyneuropathy: counteracting deposition by immunization with a Y78F TTR mutant. Lab Invest 2006;86:23–31.
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Kelly JW, Ikeda S. Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Curr Pharm Des 2008;14:3219–3230.
   PubMed Web of Science ®Google Scholar
• Cardoso I, Martins D, Ribeiro T, Merlini G, Saraiva MJ. Synergy of combined Doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models. J Transl Med 2010;8:74.
   PubMed Web of Science ®Google Scholar
• Macedo B, Magalhães J, Batista AR, Saraiva MJ. Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model. Pharmacol Res 2010;62:514–522.
   PubMed Web of Science ®Google Scholar
• Saraiva MJM, Costa PP, Goodman DS. Genetic expression of a tansthyretin mutation in typical and late-onset Portuguese families with familial amyloidotic polyneuropathy. Neurology 1986;36:1413–1417.
   PubMed Web of Science ®Google Scholar
• Nakazato M, Ikeda S, Shiomi K, Matsukura S, Yoshida K, Shimizu H, Atsumi T, Kangawa K, Matsuo H. Identification of a novel transthyretin variant (Val30-Leu) associated with familial amyloidotic polyneuropathy. FEBS Lett 1992;306:206–208.
   PubMed Web of Science ®Google Scholar
• Ikeda S. Cardiac amyloidosis: heterogenous pathogenic backgrounds. Intern Med 2004;43:1107–1114.
   PubMed Web of Science ®Google Scholar
• Okamoto S, Yamashita T, Ando Y, Ueda M, Misumi Y, Obayashi K, Horibata Y, Uchino M. Evaluation of myocardial changes in familial amyloid polyneuropathy after liver transplantation. Intern Med 2008;47:2133–2137.
   PubMed Web of Science ®Google Scholar
• Hörnsten R, Pennlert J, Wiklund U, Lindqvist P, Jensen SM, Suhr OB. Heart complications in familial transthyretin amyloidosis: impact of age and gender. Amyloid 2010;17:63–68.
   PubMed Web of Science ®Google Scholar
• Koike H, Hirayama M, Yamamoto M, Ito H, Hattori N, Umehara F, Arimura K, Ikeda S, Ando Y, Nakazato M, Age associated axonal features in HNPP with 17p11.2 deletion in Japan. J Neurol Neurosurg Psychiatry 2005;76:1109–1114.
   PubMed Web of Science ®Google Scholar
• Koike H, Morozumi S, Kawagashira Y, Iijima M, Yamamoto M, Hattori N, Tanaka F, Nakamura T, Hirayama M, Ando Y, The significance of carpal tunnel syndrome in transthyretin Val30Met familial amyloid polyneuropathy. Amyloid 2009;15:1–7.
   Google Scholar
• Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, Takahashi A. X-linked recessive bulbospinal neuronopathy, a clinicopathological study. Brain 1989;112:209–232.
   PubMed Web of Science ®Google Scholar
• Koike H, Iijima M, Sugiura M, Mori K, Hattori N, Ito H, Hirayama M, Sobue G. Alcoholic neuropathy is clinicopathologically distinct form thiamine-deficiency neuropathy. Ann Neurol 2003;54:19–29.
   PubMed Web of Science ®Google Scholar
• Koike H, Iijima M, Mori K, Yamamoto M, Hattori N, Katsuno M, Tanaka F, Watanabe H, Doyu M, Yoshikawa H, Nonmyelinating Schwann cell involvement with well-preserved unmyelinated axons in CMT1A. J Neuropathol Exp Neurol 2007;66:1027–1036.
   PubMed Web of Science ®Google Scholar
• Sobue G, Nakao N, Murakami K, Yasuda T, Sahashi K, Mitsuma T, Sasaki H, Sakaki Y, Takahashi A. Type I familial amyloid polyneuropathy. A pathological study of the peripheral nervous system. Brain 1990;113:903–919.
   Google Scholar
• Koike H, Iijima M, Mori K, Yamamoto M, Hattori N, Watanabe H, Tanaka F, Doyu M, Sobue G. Neuropathic pain correlates with myelinated fibre loss and cytokine profile in POEMS syndrome. J Neurol Neurosurg Psychiatry 2008;79:1171–1179.
   PubMed Web of Science ®Google Scholar
• Behse F, Buchthal F, Carlsen F, Knappeis GG. Unmyelinated fibres and Schwann cells of sural nerve in neuropathy. Brain 1975;98:493–510.
   PubMed Web of Science ®Google Scholar
• Koike H, Atsuta N, Adachi H, Iijima M, Katsuno M, Yasuda T, Fukada Y, Yasui K, Nakashima K, Horiuchi M, Clinicopathological features of acute autonomic and sensory neuropathy. Brain 2010;133:2881–2896.
   PubMed Web of Science ®Google Scholar
• Ochoa J, Vial JD. Behaviour of peripheral nerve structures in chronic neuropathies, with special reference to the Schwann cell. J Anat 1967;102:95–111.
   PubMed Web of Science ®Google Scholar
• Dyck PJ, Dyck PJB, Engelstad J. Pathologic alterations of nerves. Peripheral neuropathyIn: Dyck PJ, Thomas PK, editors. 4th ed.PhiladelphiaElsevier Saunders2005. pp. 733–829.
   Google Scholar
• Kato-Motozaki Y, Ono K, Shima K, Morinaga A, Machiya T, Nozaki I, Shibata-Hamaguchi A, Furukawa Y, Yanase D, Ishida C, Epidemiology of familial amyloid polyneuropathy in Japan: identification of a novel endemic focus. J Neurol Sci 2008;270:133–140.
   PubMed Web of Science ®Google Scholar
• Koike H, Mori K, Misu K, Hattori N, Ito H, Hirayama M, Sobue G. Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status. Neurology 2001;56:1727–1732.
   PubMed Web of Science ®Google Scholar
• Olofsson BO, Backman C, Karp K, Suhr OB. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation 2002;73:745–751.
   PubMed Web of Science ®Google Scholar
• SELDI-TOF mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathy. Clin Chem 2009;55:1223–1227.
   PubMed Web of Science ®Google Scholar
• Kincaid JC, Wallace MR, Benson MD. Late-onset familial amyloid polyneuropathy in an American family of English origin. Neurology 1989;39:861–863.
   PubMed Web of Science ®Google Scholar
• Hellman U, Alarcon F, Lundgren HE, Suhr OB, Bonaiti-Pellié C, Planté-Bordeneuve V. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population. Amyloid 2008;15:181–186.
   PubMed Web of Science ®Google Scholar
• Dardiotis E, Koutsou P, Papanicolaou EZ, Vonta I, Kladi A, Vassilopoulos D, Hadjigeorgiou G, Christodoulou K, Kyriakides T. Epidemiological, clinical and genetic study of familial amyloidotic polyneuropathy in Cyprus. Amyloid 2009;16:32–37.
   PubMed Web of Science ®Google Scholar
• Saporta MA, Zaros C, Cruz MW, André C, Misrahi M, Bonaïti-Pellié C, Planté-Bordeneuve V. Penetrance estimation of TTR familial amyloid polyneuropathy (type I) in Brazilian families. Eur J Neurol 2009;16:337–341.
   PubMed Web of Science ®Google Scholar
• Dyck PJ, Lambert EH. Dissociated sensation in amyloidosis. Compound action potential, quantitative histologic and teased-fiber, and electron microscopic studies of sural nerve biopsies. Arch Neurol 1969;20:490–507.
   Google Scholar
• Thomas PK, King RH. Peripheral nerve changes in amyloid neuropathy. Brain 1974;97:395–406.
   PubMed Web of Science ®Google Scholar
• Said G, Ropert A, Faux N. Length-dependent degeneration of fibers in Portuguese amyloid polyneuropathy: a clinicopathologic study. Neurology 1984;34:1025–1032.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yi S, Kimura Y, Araki S. Familial amyloidotic polyneuropathy type 1 in Kumamoto Japan: a clinicopathologic, histochemical, immunohistochemical, and ultrastructural study. Hum Pathol 1991;22: 519–527.
   PubMed Web of Science ®Google Scholar
• Tojo K, Tsuchiya-Suzuki A, Sekijima Y, Morita H, Sumita N, Ikeda S. Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy. Amyloid 2010;17:32–35.
   PubMed Web of Science ®Google Scholar
• Koike H, Sobue G. Alcoholic neuropathy. Curr Opin Neurol 2006;19:481–486.
   PubMed Web of Science ®Google Scholar
• Kim DH, Zeldenrust SR, Low PA, Dyck PJ. Quantitative sensation and autonomic test abnormalities in transthyretin amyloidosis polyneuropathy. Muscle Nerve 2009;40:363–370.
   PubMed Web of Science ®Google Scholar
• Koike H, Misu K, Hattori N, Ito S, Ichimura M, Ito H, Hirayama M, Nagamatsu M, Sasaki I, Sobue G. Postgastrectomy polyneuropathy with thiamine deficiency. J Neurol Neurosurg Psychiatry 2001;71:357–362.
   PubMed Web of Science ®Google Scholar
• Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Neurology 1991:41;617–618.
   PubMed Web of Science ®Google Scholar
• Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 2005;10:220–228.
   Google Scholar
• Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision. J Peripher Nerv Syst 2010;15:1–9.
   Web of Science ®Google Scholar
• Koike H, Ando Y, Ueda M, Kawagashira Y, Iijima M, Fujitake J, Hayashi M, Yamamoto M, Mukai E, Nakamura T, Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy. J Neurol Sci 2009;287:178–184.
   PubMed Web of Science ®Google Scholar
• Bergström J, Gustavsson A, Hellman U, Sletten K, Murphy CL, Weiss DT, Solomon A, Olofsson BO, Westermark P. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology. J Pathol 2005;206:224–232.
   PubMed Web of Science ®Google Scholar
• Ihse E, Ybo A, Suhr O, Lindqvist P, Backman C, Westermark P. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J Pathol 2008;216:253–261.
   PubMed Web of Science ®Google Scholar